Industry: Medical Devices & Consumables
Published Date: 2026-06-16
Pages: 168 Pages
Report ld: 5615651
Request Sample
Customized Report
Sterile Serological Pipette Market Size(US$)

CAGR 2026-2032
5.2%
Market Size,2032
USD 380
Million
Market Snapshot
Source: Secondary research, interviews with experts, and QYResearch analysis
The global market for Sterile Serological Pipette was estimated to be worth US$ 268 million in 2025 and is projected to reach US$ 380 million, growing at a CAGR of 5.2% from 2026 to 2032.
The potential shifts in the 2025 U.S. tariff framework pose substantial volatility risks to global markets. This report provides a comprehensive assessment of recent tariff adjustments and international strategic countermeasures on Sterile Serological Pipette cross-border industrial footprints, capital allocation patterns, regional economic interdependencies, and supply chain reconfigurations.
According to our research, the global market for medical devices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years. The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment.
This report provides a comprehensive view of the global market for Sterile Serological Pipette, covering total sales volume, sales revenue, pricing, the market share and ranking of key companies, along with analyses by region & country, by Type, and by Application.
The Sterile Serological Pipette market size, estimations, and forecasts are presented in terms of sales volume (K Units) and revenue ($ millions), with 2025 as the base year and historical and forecast data from 2021 to 2032. The report combines quantitative and qualitative analysis to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current marketplace, and make informed business decisions regarding Sterile Serological Pipette.
MARKET SEGMENTATION
CHAPTER OUTLINE
Chapter 1: Introduces the scope of the report and the global market size (value, volume, and price). It also summarizes market dynamics and Recent Developments; identifies key drivers and restraints; outlines challenges and risks for manufacturers; reviews relevant industry policies and U.S. tariff implications.
Chapter 2: Provides a detailed analysis of the Sterile Serological Pipette manufacturers' competitive landscape—including pricing, sales and revenue shares, Recent Developments plans, and mergers and acquisitions (M&A).
Chapter 3: Analyzes market segmentation by Type, presenting the size and growth potential of each segment to help readers identify blue-ocean opportunities.
Chapter 4: Analyzes market segmentation by Application, presenting the size and growth potential of each downstream segment to help readers identify blue-ocean opportunities.
Chapter 5: Presents Sterile Serological Pipette sales and revenue at the regional level. It offers a quantitative assessment of market size and growth potential by region and summarizes market development, future prospects, addressable space, and country-level market size worldwide.
Chapter 6: Presents Sterile Serological Pipette sales and revenue at the country level. It provides segmented data by Type and by Application for each country/region.
Chapter 7: Profiles key players, detailing the main companies' product sales, revenue, pricing, gross margin, product portfolios, Recent Developments, etc.
Chapter 8: Analyzes the industry value chain, including upstream suppliers and downstream applications/customers.
Chapter 9: Conclusion.
QYRESEARCH'S STRENGTHS
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:
We identify regional market threats and growth prospects to guide your overseas layout.
We adjust product portfolios in line with local consumption habits.
We unpack rivals’ operation strategies for scattered and highly concentrated industries.
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.
We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.
Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.
We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.
All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.
We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.
TABLE OF CONTENTS
1 Market Overview
1.1 Sterile Serological Pipette Product Introduction
1.2 Global Sterile Serological Pipette Market Size Forecast
1.2.1 Global Sterile Serological Pipette Sales Value (2021–2032)
1.2.2 Global Sterile Serological Pipette Sales Volume (2021–2032)
1.2.3 Global Sterile Serological Pipette Sales Price (2021–2032)
1.3 Sterile Serological Pipette Market Trends & Drivers
1.3.1 Sterile Serological Pipette Industry Trends
1.3.2 Sterile Serological Pipette Market Drivers & Opportunities
1.3.3 Sterile Serological Pipette Market Challenges
1.3.4 Sterile Serological Pipette Market Restraints
1.3.5 Impact of U.S. Tariffs
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Sterile Serological Pipette Players Revenue Ranking (2025)
2.2 Global Sterile Serological Pipette Revenue by Company (2021–2026)
2.3 Global Sterile Serological Pipette Sales Volume Ranking of Players (2025)
2.4 Global Sterile Serological Pipette Sales Volume by Company (2021–2026)
2.5 Global Sterile Serological Pipette Average Price by Company (2021–2026)
2.6 Key Manufacturers Sterile Serological Pipette Manufacturing Base and Headquarters
2.7 Key Manufacturers Sterile Serological Pipette Product Offerings
2.8 Key Manufacturers Start of Mass Production of Sterile Serological Pipette
2.9 Sterile Serological Pipette Market Competitive Analysis
2.9.1 Sterile Serological Pipette Market Concentration Rate (2021–2026)
2.9.2 Global 5 and 10 Largest Manufacturers by Sterile Serological Pipette Revenue in 2025
2.9.3 Global Companies by Tier (Tier 1, Tier 2, Tier 3), based on Sterile Serological Pipette revenue, 2025
2.10 Mergers & Acquisitions and Expansion
3 Segmentation Sterile Serological Pipette Market Classification
3.1 Introduction by Type
3.1.1 2 ml
3.1.2 5 ml
3.1.3 10 ml
3.1.4 25 ml
3.1.5 Others
3.1.6 Global Sterile Serological Pipette Sales Value by Type
3.1.6.1 Global Sterile Serological Pipette Sales Value by Type (2021 vs 2025 vs 2032)
3.1.6.2 Global Sterile Serological Pipette Sales Value, by Type (2021–2032)
3.1.6.3 Global Sterile Serological Pipette Sales Value, by Type (%), 2021–2032
3.1.7 Global Sterile Serological Pipette Sales Volume by Type
3.1.7.1 Global Sterile Serological Pipette Sales Volume by Type (2021 vs 2025 vs 2032)
3.1.7.2 Global Sterile Serological Pipette Sales Volume, by Type (2021–2032)
3.1.7.3 Global Sterile Serological Pipette Sales Volume, by Type (%), 2021–2032
3.1.8 Global Sterile Serological Pipette Average Price by Type (2021–2032)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Cell Culture
4.1.2 Bacteriology
4.1.3 Clinical Research
4.1.4 Others
4.2 Global Sterile Serological Pipette Sales Value by Application
4.2.1 Global Sterile Serological Pipette Sales Value by Application (2021 vs 2025 vs 2032)
4.2.2 Global Sterile Serological Pipette Sales Value, by Application (2021–2032)
4.2.3 Global Sterile Serological Pipette Sales Value, by Application (%), 2021–2032
4.3 Global Sterile Serological Pipette Sales Volume by Application
4.3.1 Global Sterile Serological Pipette Sales Volume by Application (2021 vs 2025 vs 2032)
4.3.2 Global Sterile Serological Pipette Sales Volume, by Application (2021–2032)
4.3.3 Global Sterile Serological Pipette Sales Volume, by Application (%), 2021–2032
4.4 Global Sterile Serological Pipette Average Price by Application (2021–2032)
5 Segmentation by Region
5.1 Global Sterile Serological Pipette Sales Value by Region
5.1.1 Global Sterile Serological Pipette Sales Value by Region: 2021 vs 2025 vs 2032
5.1.2 Global Sterile Serological Pipette Sales Value by Region (2021–2026)
5.1.3 Global Sterile Serological Pipette Sales Value by Region (2027–2032)
5.1.4 Global Sterile Serological Pipette Sales Value by Region (%), 2021–2032
5.2 Global Sterile Serological Pipette Sales Volume by Region
5.2.1 Global Sterile Serological Pipette Sales Volume by Region: 2021 vs 2025 vs 2032
5.2.2 Global Sterile Serological Pipette Sales Volume by Region (2021–2026)
5.2.3 Global Sterile Serological Pipette Sales Volume by Region (2027–2032)
5.2.4 Global Sterile Serological Pipette Sales Volume by Region (%), 2021–2032
5.3 Global Sterile Serological Pipette Average Price by Region (2021–2032)
5.4 North America
5.4.1 North America Sterile Serological Pipette Sales Value, 2021–2032
5.4.2 North America Sterile Serological Pipette Sales Value by Country (%), 2025 vs 2032
5.5 Europe
5.5.1 Europe Sterile Serological Pipette Sales Value, 2021–2032
5.5.2 Europe Sterile Serological Pipette Sales Value by Country (%), 2025 vs 2032
5.6 Asia Pacific
5.6.1 Asia Pacific Sterile Serological Pipette Sales Value, 2021–2032
5.6.2 Asia Pacific Sterile Serological Pipette Sales Value by Region (%), 2025 vs 2032
5.7 South America
5.7.1 South America Sterile Serological Pipette Sales Value, 2021–2032
5.7.2 South America Sterile Serological Pipette Sales Value by Country (%), 2025 vs 2032
5.8 Middle East & Africa
5.8.1 Middle East & Africa Sterile Serological Pipette Sales Value, 2021–2032
5.8.2 Middle East & Africa Sterile Serological Pipette Sales Value by Country (%), 2025 vs 2032
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Sterile Serological Pipette Sales Value Growth Trends, 2021 vs 2025 vs 2032
6.2 Key Countries/Regions Sterile Serological Pipette Sales Value and Sales Volume
6.2.1 Key Countries/Regions Sterile Serological Pipette Sales Value, 2021–2032
6.2.2 Key Countries/Regions Sterile Serological Pipette Sales Volume, 2021–2032
6.3 United States
6.3.1 United States Sterile Serological Pipette Sales Value, 2021–2032
6.3.2 United States Sterile Serological Pipette Sales Value by Type (%), 2025 vs 2032
6.3.3 United States Sterile Serological Pipette Sales Value by Application, 2025 vs 2032
6.4 Europe
6.4.1 Europe Sterile Serological Pipette Sales Value, 2021–2032
6.4.2 Europe Sterile Serological Pipette Sales Value by Type (%), 2025 vs 2032
6.4.3 Europe Sterile Serological Pipette Sales Value by Application, 2025 vs 2032
6.5 China
6.5.1 China Sterile Serological Pipette Sales Value, 2021–2032
6.5.2 China Sterile Serological Pipette Sales Value by Type (%), 2025 vs 2032
6.5.3 China Sterile Serological Pipette Sales Value by Application, 2025 vs 2032
6.6 Japan
6.6.1 Japan Sterile Serological Pipette Sales Value, 2021–2032
6.6.2 Japan Sterile Serological Pipette Sales Value by Type (%), 2025 vs 2032
6.6.3 Japan Sterile Serological Pipette Sales Value by Application, 2025 vs 2032
6.7 South Korea
6.7.1 South Korea Sterile Serological Pipette Sales Value, 2021–2032
6.7.2 South Korea Sterile Serological Pipette Sales Value by Type (%), 2025 vs 2032
6.7.3 South Korea Sterile Serological Pipette Sales Value by Application, 2025 vs 2032
6.8 Southeast Asia
6.8.1 Southeast Asia Sterile Serological Pipette Sales Value, 2021–2032
6.8.2 Southeast Asia Sterile Serological Pipette Sales Value by Type (%), 2025 vs 2032
6.8.3 Southeast Asia Sterile Serological Pipette Sales Value by Application, 2025 vs 2032
6.9 India
6.9.1 India Sterile Serological Pipette Sales Value, 2021–2032
6.9.2 India Sterile Serological Pipette Sales Value by Type (%), 2025 vs 2032
6.9.3 India Sterile Serological Pipette Sales Value by Application, 2025 vs 2032
7 Company Profiles
7.1 Scilogex
7.1.1 Scilogex Company Information
7.1.2 Scilogex Introduction and Business Overview
7.1.3 Scilogex Sterile Serological Pipette Sales, Revenue, Price and Gross Margin (2021–2026)
7.1.4 Scilogex Sterile Serological Pipette Product Offerings
7.1.5 Scilogex Recent Developments
7.2 Eppendorf
7.2.1 Eppendorf Company Information
7.2.2 Eppendorf Introduction and Business Overview
7.2.3 Eppendorf Sterile Serological Pipette Sales, Revenue, Price and Gross Margin (2021–2026)
7.2.4 Eppendorf Sterile Serological Pipette Product Offerings
7.2.5 Eppendorf Recent Developments
7.3 Starlab
7.3.1 Starlab Company Information
7.3.2 Starlab Introduction and Business Overview
7.3.3 Starlab Sterile Serological Pipette Sales, Revenue, Price and Gross Margin (2021–2026)
7.3.4 Starlab Sterile Serological Pipette Product Offerings
7.3.5 Starlab Recent Developments
7.4 VWR International
7.4.1 VWR International Company Information
7.4.2 VWR International Introduction and Business Overview
7.4.3 VWR International Sterile Serological Pipette Sales, Revenue, Price and Gross Margin (2021–2026)
7.4.4 VWR International Sterile Serological Pipette Product Offerings
7.4.5 VWR International Recent Developments
7.5 CELLTREAT Scientific Products
7.5.1 CELLTREAT Scientific Products Company Information
7.5.2 CELLTREAT Scientific Products Introduction and Business Overview
7.5.3 CELLTREAT Scientific Products Sterile Serological Pipette Sales, Revenue, Price and Gross Margin (2021–2026)
7.5.4 CELLTREAT Scientific Products Sterile Serological Pipette Product Offerings
7.5.5 CELLTREAT Scientific Products Recent Developments
7.6 USA Scientific
7.6.1 USA Scientific Company Information
7.6.2 USA Scientific Introduction and Business Overview
7.6.3 USA Scientific Sterile Serological Pipette Sales, Revenue, Price and Gross Margin (2021–2026)
7.6.4 USA Scientific Sterile Serological Pipette Product Offerings
7.6.5 USA Scientific Recent Developments
7.7 CAPP
7.7.1 CAPP Company Information
7.7.2 CAPP Introduction and Business Overview
7.7.3 CAPP Sterile Serological Pipette Sales, Revenue, Price and Gross Margin (2021–2026)
7.7.4 CAPP Sterile Serological Pipette Product Offerings
7.7.5 CAPP Recent Developments
7.8 Globe Scientific
7.8.1 Globe Scientific Company Information
7.8.2 Globe Scientific Introduction and Business Overview
7.8.3 Globe Scientific Sterile Serological Pipette Sales, Revenue, Price and Gross Margin (2021–2026)
7.8.4 Globe Scientific Sterile Serological Pipette Product Offerings
7.8.5 Globe Scientific Recent Developments
7.9 Abdos Labtech
7.9.1 Abdos Labtech Company Information
7.9.2 Abdos Labtech Introduction and Business Overview
7.9.3 Abdos Labtech Sterile Serological Pipette Sales, Revenue, Price and Gross Margin (2021–2026)
7.9.4 Abdos Labtech Sterile Serological Pipette Product Offerings
7.9.5 Abdos Labtech Recent Developments
7.10 SPL Life Sciences
7.10.1 SPL Life Sciences Company Information
7.10.2 SPL Life Sciences Introduction and Business Overview
7.10.3 SPL Life Sciences Sterile Serological Pipette Sales, Revenue, Price and Gross Margin (2021–2026)
7.10.4 SPL Life Sciences Sterile Serological Pipette Product Offerings
7.10.5 SPL Life Sciences Recent Developments
7.11 MIDSCI
7.11.1 MIDSCI Company Information
7.11.2 MIDSCI Introduction and Business Overview
7.11.3 MIDSCI Sterile Serological Pipette Sales, Revenue, Price and Gross Margin (2021–2026)
7.11.4 MIDSCI Sterile Serological Pipette Product Offerings
7.11.5 MIDSCI Recent Developments
7.12 Thermo Fisher Scientific
7.12.1 Thermo Fisher Scientific Company Information
7.12.2 Thermo Fisher Scientific Introduction and Business Overview
7.12.3 Thermo Fisher Scientific Sterile Serological Pipette Sales, Revenue, Price and Gross Margin (2021–2026)
7.12.4 Thermo Fisher Scientific Sterile Serological Pipette Product Offerings
7.12.5 Thermo Fisher Scientific Recent Developments
7.13 Tarsons
7.13.1 Tarsons Company Information
7.13.2 Tarsons Introduction and Business Overview
7.13.3 Tarsons Sterile Serological Pipette Sales, Revenue, Price and Gross Margin (2021–2026)
7.13.4 Tarsons Sterile Serological Pipette Product Offerings
7.13.5 Tarsons Recent Developments
7.14 Medline Industries
7.14.1 Medline Industries Company Information
7.14.2 Medline Industries Introduction and Business Overview
7.14.3 Medline Industries Sterile Serological Pipette Sales, Revenue, Price and Gross Margin (2021–2026)
7.14.4 Medline Industries Sterile Serological Pipette Product Offerings
7.14.5 Medline Industries Recent Developments
7.15 Corning
7.15.1 Corning Company Information
7.15.2 Corning Introduction and Business Overview
7.15.3 Corning Sterile Serological Pipette Sales, Revenue, Price and Gross Margin (2021–2026)
7.15.4 Corning Sterile Serological Pipette Product Offerings
7.15.5 Corning Recent Developments
7.16 Greiner Bio-One
7.16.1 Greiner Bio-One Company Information
7.16.2 Greiner Bio-One Introduction and Business Overview
7.16.3 Greiner Bio-One Sterile Serological Pipette Sales, Revenue, Price and Gross Margin (2021–2026)
7.16.4 Greiner Bio-One Sterile Serological Pipette Product Offerings
7.16.5 Greiner Bio-One Recent Developments
7.17 Gilson
7.17.1 Gilson Company Information
7.17.2 Gilson Introduction and Business Overview
7.17.3 Gilson Sterile Serological Pipette Sales, Revenue, Price and Gross Margin (2021–2026)
7.17.4 Gilson Sterile Serological Pipette Product Offerings
7.17.5 Gilson Recent Developments
7.18 Sartorius
7.18.1 Sartorius Company Information
7.18.2 Sartorius Introduction and Business Overview
7.18.3 Sartorius Sterile Serological Pipette Sales, Revenue, Price and Gross Margin (2021–2026)
7.18.4 Sartorius Sterile Serological Pipette Product Offerings
7.18.5 Sartorius Recent Developments
7.19 Bio-Rad Laboratories
7.19.1 Bio-Rad Laboratories Company Information
7.19.2 Bio-Rad Laboratories Introduction and Business Overview
7.19.3 Bio-Rad Laboratories Sterile Serological Pipette Sales, Revenue, Price and Gross Margin (2021–2026)
7.19.4 Bio-Rad Laboratories Sterile Serological Pipette Product Offerings
7.19.5 Bio-Rad Laboratories Recent Developments
7.20 Nest Scientific
7.20.1 Nest Scientific Company Information
7.20.2 Nest Scientific Introduction and Business Overview
7.20.3 Nest Scientific Sterile Serological Pipette Sales, Revenue, Price and Gross Margin (2021–2026)
7.20.4 Nest Scientific Sterile Serological Pipette Product Offerings
7.20.5 Nest Scientific Recent Developments
7.21 Biologix
7.21.1 Biologix Company Information
7.21.2 Biologix Introduction and Business Overview
7.21.3 Biologix Sterile Serological Pipette Sales, Revenue, Price and Gross Margin (2021–2026)
7.21.4 Biologix Sterile Serological Pipette Product Offerings
7.21.5 Biologix Recent Developments
7.22 TPP
7.22.1 TPP Company Information
7.22.2 TPP Introduction and Business Overview
7.22.3 TPP Sterile Serological Pipette Sales, Revenue, Price and Gross Margin (2021–2026)
7.22.4 TPP Sterile Serological Pipette Product Offerings
7.22.5 TPP Recent Developments
7.23 Sarstedt
7.23.1 Sarstedt Company Information
7.23.2 Sarstedt Introduction and Business Overview
7.23.3 Sarstedt Sterile Serological Pipette Sales, Revenue, Price and Gross Margin (2021–2026)
7.23.4 Sarstedt Sterile Serological Pipette Product Offerings
7.23.5 Sarstedt Recent Developments
7.24 Merck
7.24.1 Merck Company Information
7.24.2 Merck Introduction and Business Overview
7.24.3 Merck Sterile Serological Pipette Sales, Revenue, Price and Gross Margin (2021–2026)
7.24.4 Merck Sterile Serological Pipette Product Offerings
7.24.5 Merck Recent Developments
7.25 Argos Technologies
7.25.1 Argos Technologies Company Information
7.25.2 Argos Technologies Introduction and Business Overview
7.25.3 Argos Technologies Sterile Serological Pipette Sales, Revenue, Price and Gross Margin (2021–2026)
7.25.4 Argos Technologies Sterile Serological Pipette Product Offerings
7.25.5 Argos Technologies Recent Developments
7.26 HiMedia
7.26.1 HiMedia Company Information
7.26.2 HiMedia Introduction and Business Overview
7.26.3 HiMedia Sterile Serological Pipette Sales, Revenue, Price and Gross Margin (2021–2026)
7.26.4 HiMedia Sterile Serological Pipette Product Offerings
7.26.5 HiMedia Recent Developments
8 Industry Chain Analysis
8.1 Sterile Serological Pipette Industrial Chain
8.2 Sterile Serological Pipette Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Key Suppliers of Raw Materials
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customer Analysis)
8.5 Sales Model and Sales Channelss
8.5.1 Sterile Serological Pipette Sales Model
8.5.2 Sales Channels
8.5.3 Sterile Serological Pipette Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.1.1 Research Programs/Design
10.1.1.2 Market Size Estimation
10.1.1.3 Market Breakdown and Data Triangulation
10.1.2 Data Source
10.1.2.1 Secondary Sources
10.1.2.2 Primary Sources
10.2 Author Details
10.3 Disclaimer
TABLE OF FIGURES
List of Tables
List of Figures
KEY QUESTIONS ADDRESSED BY THE REPORT
Related Reports
The global Sterile Serological Pipette market was valued at US$ 268 million in 2025 and is anticipated to reach US$ 380 million by 2032, at a CAGR of 5.2% from 2026 to 2032.
Published Date: 2026-04-17
Pages: 157
USD 2900.00
(Single User License)
The global Sterile Serological Pipette market size was US$ 256 million in 2024 and is forecast to a readjusted size of US$ 363 million by 2031 with a CAGR of 5.2% during the forecast period 2025-2031.
Published Date: 2025-11-02
Pages: 128
USD 4250.00
(Single User License)
The global Sterile Serological Pipette market is projected to grow from US$ 256 million in 2024 to US$ 363 million by 2031, at a CAGR of 5.2% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2025-11-02
Pages: 213
USD 4900.00
(Single User License)
The global market for Sterile Serological Pipette was estimated to be worth US$ 256 million in 2024 and is forecast to a readjusted size of US$ 363 million by 2031 with a CAGR of 5.2% during the forecast period 2025-2031.
Published Date: 2025-01-13
Pages: 187
USD 3950.00
(Single User License)
The global market for Sterile Serological Pipette was valued at US$ 256 million in the year 2024 and is projected to reach a revised size of US$ 363 million by 2031, growing at a CAGR of 5.2% during the forecast period.
Published Date: 2025-01-13
Pages: 120
USD 2900.00
(Single User License)
The global Sterile Serological Pipette market is projected to grow from US$ 244.3 million in 2024 to US$ 331.1 million by 2030, at a Compound Annual Growth Rate (CAGR) of 5.2% during the forecast period.
Published Date: 2024-04-26
Pages: 126
USD 4900.00
(Single User License)
The global Sterile Serological Pipette market was valued at US$ 232 million in 2023 and is anticipated to reach US$ 331.1 million by 2030, witnessing a CAGR of 5.2% during the forecast period 2024-2030.
Published Date: 2024-02-05
Pages: 113
USD 2900.00
(Single User License)
The global Sterile Serological Pipette market was valued at US$ 268 million in 2025 and is anticipated to reach US$ 380 million by 2032, at a CAGR of 5.2% from 2026 to 2032.
Published: 2026-04-17
Pages: 157
The global Sterile Serological Pipette market size was US$ 256 million in 2024 and is forecast to a readjusted size of US$ 363 million by 2031 with a CAGR of 5.2% during the forecast period 2025-2031.
Published: 2025-11-02
Pages: 128
The global Sterile Serological Pipette market is projected to grow from US$ 256 million in 2024 to US$ 363 million by 2031, at a CAGR of 5.2% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2025-11-02
Pages: 213
The global market for Sterile Serological Pipette was estimated to be worth US$ 256 million in 2024 and is forecast to a readjusted size of US$ 363 million by 2031 with a CAGR of 5.2% during the forecast period 2025-2031.
Published: 2025-01-13
Pages: 187
The global market for Sterile Serological Pipette was valued at US$ 256 million in the year 2024 and is projected to reach a revised size of US$ 363 million by 2031, growing at a CAGR of 5.2% during the forecast period.
Published: 2025-01-13
Pages: 120
The global Sterile Serological Pipette market is projected to grow from US$ 244.3 million in 2024 to US$ 331.1 million by 2030, at a Compound Annual Growth Rate (CAGR) of 5.2% during the forecast period.
Published: 2024-04-26
Pages: 126
The global Sterile Serological Pipette market was valued at US$ 232 million in 2023 and is anticipated to reach US$ 331.1 million by 2030, witnessing a CAGR of 5.2% during the forecast period 2024-2030.
Published: 2024-02-05
Pages: 113
REPORT COVERAGE
DESCRIPTION
OVERVIEW
MARKET SEGMENTATION
CHAPTER OUTLINE
QYRESEARCH'S STRENGTHS
TABLE OF CONTENTS
TABLE OF FIGURES
RLEATED REPORTS
INTEREST IN THIS REPORT?
Get A Free Sample
Request For Quotation
OR
NEED A CUSTOMIZED REPORT?
Customized Report
Request Sample
Pre-Order Enquiry
Add to Cart
Buy Now